Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction

李　慧; 林岩松

doi:10.19401/j.cnki.1007-3639.2018.07.001

您当前的位置：

首页 >

文章列表页 >

Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction

更新时间：2026-01-27

- Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction
- China Oncology Vol. 28, Issue 7, Pages: 481-486(2018)
- 作者机构：
  
  1. 中国医学科学院北京协和医学院北京协和医院核医学科,北京,100730
  2. 核医学分子靶向诊疗北京市重点实验室,北京,100730
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2018.07.001
  CLC： R736.1
- Published Online：10 August 2018，
  
  Published：10 August 2018
- 稿件说明：
移动端阅览
李　慧,林岩松. 核医学分子影像在分化型甲状腺癌中的应用现状与进展[J]. 中国癌症杂志, 2018, 28(7): 481-486.

李　慧, 林岩松. Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction[J]. China Oncology, 2018, 28(7): 481-486.
李　慧,林岩松. 核医学分子影像在分化型甲状腺癌中的应用现状与进展[J]. 中国癌症杂志, 2018, 28(7): 481-486. DOI： 10.19401/j.cnki.1007-3639.2018.07.001.

李　慧, 林岩松. Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction[J]. China Oncology, 2018, 28(7): 481-486. DOI： 10.19401/j.cnki.1007-3639.2018.07.001.

摘要

分化型甲状腺癌因其发病率逐年升高而引人关注，核医学诊疗是其诊疗过程中重要的一环。随着新型示踪剂的发展，核医学分子影像检查对于在体显示甲状腺癌特定的分子特征及表达水平有重要价值，并可实现基于在体分子特征评估指导下的精准靶向治疗。现就核医学分子影像在评估分化型甲状腺癌分化表型特征和非分化表型特征两方面的应用与进展进行综述。

Abstract

With the increasing of incidence

differentiated thyroid cancer (DTC) has become a global concern.Nuclear medicine plays an important role in the diagnosis and treatment of DTC. With the development of new tracers

molecular imaging of nuclear medicine has shown great value in demonstrating the molecular characteristics and its expression level of DTC

and can be used to guide the precise target therapy based on molecular nuclear imaging in vivo. Here we present this review on the current status and future direction of the application of molecular nuclear imaging in evaluating the differentiated and non-differentiated phenotype characteristics in DTC.

关键词

Keywords

references

Views

3331

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in external beam radiotherapy (EBRT) for differentiated thyroid cancer

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in ultrasound, CT, MRI and ablation of thyroid nodules and differentiated thyroid cancer

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: perioperative assessment and management of parathyroid function and precision individualized management of postoperative TSH suppression in adults with differentiated thyroid cancer

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in nuclear medicine diagnosis and treatment of differentiated thyroid cancer

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: precision treatment guided by genotyping

Related Author

Xiaorong HOU

Xiaoliang LIU

Bo ZHANG

Chenyi WANG

Ruyu LIU

Yiming WU

Chuyao FENG

Ying GAO

Related Institution

Department of Radiation Oncology, Peking Union Medical College Hospital & Chinese Academy of Medical Sciences

Japan Friendship Hospital (Institute of Clinical Medical Sciences), Peking Union Medical College, Chinese Academy of Medical Sciences,, China

Department of Ultrasound, China-Japan Friendship Hospital

National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital

Department of Endocrinology, Zhejiang Provincial People’s Hospital

AI问答

⁰